자료실 목록

논문

해면 종 미상

인슐린 경피 전달을 위한 항균 스펀지 마이크로니들의 설계·제조·평가

  • 경피 약물 전달
  • 2025
Zhang X, Zhang Y, Zheng H, Yang X, Zou S, Chen J
Eur J Pharm Biopharm
DOI: 10.1016/j.ejpb.2024.114586
원문 보기 (DOI)PDF 준비 중

초록 (Abstract)

출처에서 그대로 옮긴 원문입니다. 아래 원문 링크로 전문을 보실 수 있습니다.

Transdermal drug delivery systems hold promise, but their effectiveness is often constrained by the skin's barrier. Microneedles (MNs) improve drug permeability by creating micro-channels in the skin, yet they continue to face challenges such as infection risks and safety concerns. To overcome these challenges, a novel antimicrobial sponge MNs (ASMNs@PVP-INS) modified with polyvinylpyrrolidone (PVP) for insulin (INS) delivery was designed. Mechanical testing demonstrated that these MNs possess excellent mechanical strength, capable of withstanding at least 0.11 N per needle without rupture. In vitro drug penetration tests revealed that the MNs consistently released over 75 % of INS within a 6 h. In an animal model, ASMNs@PVP-INS reduced initial blood glucose levels from 22.4 to 5.72 mmol/L, effectively maintaining glucose control for more than 6 h without inducing hypoglycemia. Additionally, agar diffusion assays indicated that INS loading did not compromise the antimicrobial properties of antimicrobial sponge MNs (ASMNs). Skin irritation tests showed that ASMNs@PVP-INS exhibited mild irritation (PII < 0.6), with skin damage fully recovering within 8 h. Safety assessments indicated no significant toxicity to mice, with biochemical markers remaining within normal ranges, thereby confirming their good biocompatibility. In conclusion, ASMNs@PVP-INS hold promise as a novel drug delivery vehicle.

키워드

AntimicrobialDiabetesInsulinMicroneedlesSafetyTransdermal

인용 정보

Zhang X, Zhang Y, Zheng H, Yang X, Zou S, Chen J (2025). Design, fabrication, and evaluation of antimicrobial sponge microneedles for the transdermal delivery of insulin. Eur J Pharm Biopharm. https://doi.org/10.1016/j.ejpb.2024.114586